Fund shareholders of Cytokinetics Inc
ISIN US23282W6057 · United States · LEI 549300BE5DY1HW7IHA64
- Fund shareholders
- 463
- Of which ETFs
- 86 377 other funds
- Value held
- 4.6B $ 355.9M SEK
- Share of capital
- 50.8 % of 139M shares on Aug 4, 2026
463 funds hold this company. This table lists the 461 that declare it in a regulatory filing. The other 2 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 5,105,689 | 336.5M $ | 0.51 % | 3.67 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Mid-Cap ETF iShares Trust | 4,048,023 | 266.8M $ | 0.25 % | 2.91 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,902,739 | 257.2M $ | 0.01 % | 2.81 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 3,482,614 | 222.8M $ | 0.60 % | 2.51 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 2,923,781 | 192.7M $ | 0.27 % | 2.10 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,839,773 | 187.2M $ | 0.11 % | 2.04 % | as of Mar 31, 2026 ↗ |
| Fidelity OTC Portfolio Fidelity Securities Fund | 2,271,300 | 145.3M $ | 0.36 % | 1.63 % | as of Apr 30, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 2,114,898 | 139.4M $ | 0.17 % | 1.52 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 1,686,600 | 111.2M $ | 0.49 % | 1.21 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,590,770 | 104.8M $ | 0.27 % | 1.14 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,365,835 | 90M $ | 0.11 % | 0.98 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1,331,453 | 87.8M $ | 1.18 % | 0.96 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1,183,484 | 75.7M $ | 0.23 % | 0.85 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 1,178,125 | 77.7M $ | 0.84 % | 0.85 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 1,100,581 | 72.5M $ | 0.52 % | 0.79 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 1,072,574 | 70.7M $ | 0.88 % | 0.77 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1,045,102 | 68.9M $ | 1.11 % | 0.75 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 929,552 | 57.8M $ | 0.03 % | 0.67 % | as of Feb 28, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 912,972 | 60.2M $ | 0.48 % | 0.66 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 896,972 | 59.1M $ | 0.73 % | 0.65 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 684,813 | 43.8M $ | 0.20 % | 0.49 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 663,136 | 43.7M $ | 0.40 % | 0.48 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 645,140 | 40.1M $ | 0.10 % | 0.46 % | as of Feb 28, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 600,000 | 37.3M $ | 0.60 % | 0.43 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF SPDR SERIES TRUST | 597,189 | 39.4M $ | 0.25 % | 0.43 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 593,636 | 36.9M $ | 0.18 % | 0.43 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 586,266 | 38.6M $ | 0.89 % | 0.42 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 578,745 | 36M $ | 0.24 % | 0.42 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 561,677 | 35.9M $ | 0.43 % | 0.40 % | as of Apr 30, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 510,356 | 33.6M $ | 0.51 % | 0.37 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 503,175 | 31.3M $ | 0.59 % | 0.36 % | as of Feb 28, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 502,775 | 32.2M $ | 0.46 % | 0.36 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 479,028 | 31.6M $ | 1.99 % | 0.34 % | as of Mar 31, 2026 ↗ |
| iShares S&P Mid-Cap 400 Growth ETF iShares Trust | 400,888 | 26.4M $ | 0.27 % | 0.29 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 400,000 | 25.6M $ | 0.55 % | 0.29 % | as of Apr 30, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 382,314 | 25.2M $ | 0.54 % | 0.27 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 353,776 | 22.6M $ | 0.45 % | 0.25 % | as of Apr 30, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 349,900 | 22.4M $ | 1.06 % | 0.25 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 341,233 | 21.2M $ | 0.10 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Small Cap Growth Fund American Century Mutual Funds, Inc. | 334,272 | 21.4M $ | 0.42 % | 0.24 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 330,605 | 20.6M $ | 0.15 % | 0.24 % | as of Feb 28, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 329,900 | 20.5M $ | 0.06 % | 0.24 % | as of Feb 28, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 319,300 | 21M $ | 0.52 % | 0.23 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 312,871 | 20M $ | 1.05 % | 0.23 % | as of Apr 30, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 307,200 | 20.2M $ | 0.25 % | 0.22 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Equity Growth Fund Fidelity Advisor Series I | 291,801 | 18.2M $ | 0.15 % | 0.21 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 290,400 | 18.1M $ | 0.02 % | 0.21 % | as of Feb 28, 2026 ↗ |
| iShares S&P Mid-Cap 400 Value ETF iShares Trust | 285,745 | 18.8M $ | 0.24 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 281,164 | 18M $ | 0.42 % | 0.20 % | as of Apr 30, 2026 ↗ |
| VIP Growth Portfolio Variable Insurance Products Fund | 269,100 | 17.7M $ | 0.17 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 267,000 | 17.1M $ | 0.59 % | 0.19 % | as of Apr 30, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 262,688 | 16.8M $ | 0.23 % | 0.19 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 249,600 | 16.5M $ | 0.13 % | 0.18 % | as of Mar 31, 2026 ↗ |
| Lannebo Global Lannebo Kapitalförvaltning AB | 228,000 | 143.2M SEK | 0.71 % | 0.16 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 227,934 | 14.2M $ | 0.01 % | 0.16 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 218,000 | 13.9M $ | 0.48 % | 0.16 % | as of Apr 30, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 214,074 | 13.7M $ | 0.56 % | 0.15 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 205,700 | 13.6M $ | 0.49 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 205,000 | 128.7M SEK | 0.58 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Value Fund Fidelity Securities Fund | 203,453 | 13M $ | 0.26 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Fidelity OTC K6 Portfolio Fidelity Securities Fund | 203,400 | 13M $ | 0.39 % | 0.15 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 202,652 | 13.4M $ | 0.61 % | 0.15 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 202,120 | 12.6M $ | 0.60 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 194,679 | 12.8M $ | 0.27 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Small/Mid Cap Growth Alpha ETF Janus Detroit Street Trust | 189,801 | 12.1M $ | 1.24 % | 0.14 % | as of Apr 30, 2026 ↗ |
| VANGUARD S&P MID-CAP 400 INDEX FUND VANGUARD ADMIRAL FUNDS | 186,109 | 11.6M $ | 0.22 % | 0.13 % | as of Feb 28, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 184,777 | 11.5M $ | 0.18 % | 0.13 % | as of Feb 27, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 180,870 | 11.3M $ | 0.01 % | 0.13 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 172,745 | 10.7M $ | 0.23 % | 0.12 % | as of Feb 27, 2026 ↗ |
| American Funds Global Insight Fund American Funds Global Insight Fund | 161,996 | 10.4M $ | 0.05 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Small Cap Fund Fidelity Advisor Series I | 161,200 | 10M $ | 0.45 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 161,063 | 10.3M $ | 0.99 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 160,000 | 10.5M $ | 0.05 % | 0.12 % | as of Mar 31, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 158,500 | 10.4M $ | 0.38 % | 0.11 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 157,441 | 10.4M $ | 0.01 % | 0.11 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Equity Fund JNL Series Trust | 152,896 | 10.1M $ | 1.11 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Discovery Fund Fidelity Hastings Street Trust | 149,801 | 9.9M $ | 0.17 % | 0.11 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 148,708 | 9.8M $ | 0.12 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 146,000 | 9.6M $ | 0.51 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 143,425 | 9.2M $ | 0.23 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 138,684 | 9.1M $ | 0.04 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 133,319 | 8.8M $ | 0.21 % | 0.10 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 131,757 | 8.4M $ | 0.36 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust | 131,696 | 8.7M $ | 0.48 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Columbia Small Cap Value and Inflection Fund COLUMBIA FUNDS SERIES TRUST | 128,610 | 8M $ | 0.97 % | 0.09 % | as of Feb 28, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 125,119 | 8.2M $ | 0.24 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Impax Small Cap Fund IMPAX FUNDS SERIES TRUST I | 125,000 | 8.2M $ | 1.11 % | 0.09 % | as of Mar 31, 2026 ↗ |
| JNL Mid Cap Index Fund JNL Series Trust | 123,477 | 8.1M $ | 0.25 % | 0.09 % | as of Mar 31, 2026 ↗ |
| William Blair Small Cap Growth Fund WILLIAM BLAIR FUNDS | 120,490 | 7.9M $ | 0.80 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Voya Small Cap Growth Fund Voya Equity Trust | 120,263 | 7.5M $ | 0.40 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Small Cap Core Fund Fidelity Concord Street Trust | 115,651 | 7.4M $ | 0.46 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small/Mid Cap Growth Fund Goldman Sachs Trust | 112,482 | 7M $ | 0.57 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 112,392 | 7.4M $ | 0.00 % | 0.08 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 108,545 | 7.2M $ | 0.06 % | 0.08 % | as of Mar 31, 2026 ↗ |
| William Blair Small-Mid Cap Growth Fund WILLIAM BLAIR FUNDS | 108,500 | 7.2M $ | 0.64 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Stock Selector Mid Cap Fund Fidelity Advisor Series I | 107,100 | 6.7M $ | 0.29 % | 0.08 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF SPDR SERIES TRUST | 100,517 | 6.6M $ | 0.27 % | 0.07 % | as of Mar 31, 2026 ↗ |
| EQ/Mid Cap Index Portfolio EQ Advisors Trust | 100,218 | 6.6M $ | 0.25 % | 0.07 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 100,000 | 6.6M $ | 0.66 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Value Fund Goldman Sachs Trust | 99,713 | 6.2M $ | 0.66 % | 0.07 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Thornburg Focus Growth Fund THORNBURG INVESTMENT TRUST | 2.78 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.06 % | as of Sep 30, 2025 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.99 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1.54 % | as of Mar 31, 2026 ↗ |
| Tema Heart & Health ETF Tema ETF Trust | 1.47 % | as of Feb 28, 2026 ↗ |
| Brown Advisory Sustainable Small-Cap Core Fund Brown Advisory Funds | 1.44 % | as of Mar 31, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 1.38 % | as of Feb 28, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.35 % | as of Feb 28, 2026 ↗ |
| AMG GW&K Small Cap Value Fund AMG Funds | 1.28 % | as of Mar 31, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 1.26 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 454 | +19 | 70,064,407 | -2.3 % |
| 2026Q1 | 435 | +36 | 71,728,244 | +5.3 % |
| 2025Q4 | 399 | +13 | 68,118,302 | +1.9 % |
| 2025Q3 | 386 | -18 | 66,855,548 | +8.4 % |
| 2025Q2 | 404 | -4 | 61,652,413 | -1.6 % |
| 2025Q1 | 408 | 0 | 62,648,882 | +0.2 % |
| 2024Q4 | 408 | +3 | 62,522,434 | +5.5 % |
| 2024Q3 | 405 | -12 | 59,278,765 | +17.2 % |
| 2024Q2 | 417 | +46 | 50,562,274 | -7.4 % |
| 2024Q1 | 371 | +30 | 54,588,837 | -5.1 % |
| 2023Q4 | 341 | 57,517,240 |
Institutional managers
429 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 17,523,840 | 1.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 16,548,011 | 1.1B $ | as of Mar 31, 2026 |
| FMR LLC | 10,723,140 | 706.8M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 8,009,489 | 527.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,745,193 | 378.7M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 3,333,333 | 219.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,215,415 | 212M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 3,125,436 | 206M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 2,721,158 | 179.4M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,205,758 | 145.4M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,077,277 | 136.9M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 1,661,248 | 109.5M $ | as of Mar 31, 2026 |
| Integral Health Asset Management, LLC | 1,600,000 | 105.5M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,584,321 | 104.4K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,505,075 | 99.2M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 1,480,857 | 97.6M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,441,634 | 95M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,397,045 | 92.1M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 1,374,320 | 90.6M $ | as of Mar 31, 2026 |
| Capital International Investors | 1,338,803 | 88.2M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 1,159,879 | 76.4M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,099,858 | 72.5M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 1,093,485 | 72.1M $ | as of Mar 31, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1,087,591 | 71.7M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 1,006,185 | 66.3M $ | as of Mar 31, 2026 |
Declared shareholders of Cytokinetics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 9.00 % | 11,135,192 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.21 % | 6,422,042 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Cytokinetics Inc
32 funds declare 37 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Cytokinetics Inc". https://titelia.com/en/stocks/cytokinetics-inc-US23282W6057